Here we report a novel siRNA delivery system for cancer therapy. Tamoxifen was used to modify a pH sensitive lipid-based nanocarrier for targeted delivery of , siRNAs to ER positive cancer cells. Its potential to serve as a delivery platform and a therapeutic agent was evaluated in vitro and in vivo.
展开▼
